Capricor Therapeutics, Inc. (CAPR) has a market capitalization of $1.59B and trades at $34.72. The 52-week range is 4.3-40.37.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -15.4, Earnings Per Share (EPS) of $-2.26.
The stock has a beta of 0.48, operates in the Healthcare sector.
